Skip to main content

Table 1 Patient characteristics and Quality of life rating

From: Effects of androgen deprivation on brain function in prostate cancer patients – a prospective observational cohort analysis

Group

ADT n = 15

Control n = 15

Age

69.0 ± 5.3 y

66.1 ± 6.2 y

Education

9th grade: 1

9th grade: 1

 

High School/GED: 5

High School/GED: 5

 

College 1-3 years: 3

College 1-3 years: 3

 

College graduate: 2

College graduate: 3

 

Post-graduate: 4

Post-graduate: 3

MMSE

29.0 ± 1.3

29.5 ± 0.6

Cancer staging

Stage II: 13

Stage I: 1

 

Stage III: 2

Stage II: 12

  

Stage III: 2

Local therapy

Radiation 100%

Radiation 26.7%

  

Surgery 66.7%

  

Surgery + Radiation 6.7%

QOL at baseline

115 ± 22

132 ± 18

QOL of life at 6 months

110 ± 23

128 ± 21

Testosterone at 6 months

0.14 ± 0.10 ng/ml

2.84 ± 0.94 ng/ml

  1. Note: ADT: Androgen Deprivation Therapy; GED: General Education Development Test; MMSE: Mini Mental State Examination; QOL: FACT-P quality of life score; there is no difference between groups in age (t = 1.172, p = 0.588, two-sided two-sample t test); there is no difference between groups in MMSE score (t = 1.417, p = 0.167, two-sided two-sample t test); staging follows the current guidelines of the 2010 American Joint Committee on Cancer (AJCC) that include Gleason score in the staging; there is also no difference across the two time points in the change of QOL between groups (F = 0.056, p = 0.814, interaction, repeated measures analysis of variance).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us